James Parmelee touted these five stocks in July of 2006.
Parmelee, an analyst with Credit Suisse First Boston, recommended Avery Dennison (AVY), Glaxosmithkline (GSK), Kimberly Clark (KMB), Paychex (PAYX), Wal-Mart (WMT). After nearly one year, four of the five are up so far.
AVY > Then: $57.84. Now: $67.72. Change: +17.1%.
GSK > Then: $55.28. Now: $52.64. Change: -4.8%.
KMB > Then: $60.19. Now: $66.56. Change: +10.6%.
PAYX > Then: $33.81. Now: $42.67. Change: +26.2%
WMT > Then: $43.53. Now: $48.06. Change: +10.4%.
Overall, on a weighted basis, Parmelee's picks are up 11.9%. The big winner is Paychex, which is also his only selection with a P/E above 18. I like these stocks because they're fundamentally sound, fairly low risk and still climbing, with the exception of Glaxo.
Showing posts with label KMB. Show all posts
Showing posts with label KMB. Show all posts
Sunday, July 22, 2007
Subscribe to:
Posts (Atom)
